NCT04237649 2025-05-18
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Novartis
Phase EARLY_PHASE1 Terminated
Novartis
Mayo Clinic
Thunder Bay Regional Health Research Institute
Children's Hospital Medical Center, Cincinnati
Peregrine Pharmaceuticals